TipRanks
Go Ultimate55% OFF

Chandler Robinson Insider Profile

11 Followers

Chandler Robinson, CEO, Director at Monopar Therapeutics Inc, holds 166.94K shares in Monopar Therapeutics Inc (Ticker: MNPR).

Chandler Robinson's Trading History

MNPR
Monopar Therapeutics Inc
Oct 20, 2026CEO, DirectorUninformative Sell55.28K$11.74M
MNPR
Insider Shares: 166.94K (2.49%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Oct 20, 2026Uninformative Sell$55.28K597$92.59―
Sep 28, 2026Uninformative Sell$2.56M29,056$87.99―
Sep 28, 2026Uninformative Buy$631.68K29,056$21.74―
Jul 02, 2026Uninformative Buy$813.77K8,789$92.59―
Apr 02, 2026Uninformative Buy$260.80K4,760$54.79―

You May Also Like

Chandler Robinson insider profile FAQ

What stocks does Chandler Robinson hold?
Chandler Robinson holds: MNPR stocks.
What was Chandler Robinson’s latest transaction?
Chandler Robinson’s latest transaction was an Uninformative Sell of $55.28K.
What is Chandler Robinson's role in Monopar Therapeutics Inc?
Chandler Robinson's role in Monopar Therapeutics Inc is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.